LFG
CLLS

Larson Financial Group’s Cellectis CLLS Stock Holding History

Larson Financial Group’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$238 Buy
+75
New +$287 ﹤0.01% 3427

Other funds holding CLLS

BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Larson Financial Group's CLLS Position: Q1 2026 in Review

Larson Financial Group opened a new position in Cellectis (CLLS) in Q1 2026: 75 shares worth $238. The stake represents ﹤0.01% of the portfolio and ranks #3427 among its holdings.

32 funds tracked by Wall St. Rank hold CLLS as of Q1 2026.

  • Larson Financial Group held 75 shares of Cellectis worth $238 as of Q1 2026.
  • Cellectis was a new Larson Financial Group position in Q1 2026.
  • Cellectis made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #3427 holding.
  • 32 funds tracked by Wall St. Rank held Cellectis as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.